- Home
- LSEA vs PRQR Comparison
LSEA vs PRQR Comparison
Compare LSEA & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- PRQR
- Stock Information
- Founded
- LSEA 2013
- PRQR 2012
- Country
- LSEA United States
- PRQR Netherlands
- Employees
- LSEA N/A
- PRQR N/A
- Industry
- LSEA Homebuilding
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- LSEA Consumer Discretionary
- PRQR Health Care
- Exchange
- LSEA Nasdaq
- PRQR Nasdaq
- Market Cap
- LSEA 222.1M
- PRQR 309.5M
- IPO Year
- LSEA N/A
- PRQR 2014
- Fundamental
- Price
- LSEA $6.10
- PRQR $1.55
- Analyst Decision
- LSEA Buy
- PRQR Strong Buy
- Analyst Count
- LSEA 4
- PRQR 6
- Target Price
- LSEA $13.50
- PRQR $9.00
- AVG Volume (30 Days)
- LSEA 200.4K
- PRQR 678.2K
- Earning Date
- LSEA 05-12-2025
- PRQR 05-08-2025
- Dividend Yield
- LSEA N/A
- PRQR N/A
- EPS Growth
- LSEA N/A
- PRQR N/A
- EPS
- LSEA 0.47
- PRQR N/A
- Revenue
- LSEA $1,550,337,000.00
- PRQR $21,212,711.00
- Revenue This Year
- LSEA N/A
- PRQR $6.44
- Revenue Next Year
- LSEA $3.52
- PRQR N/A
- P/E Ratio
- LSEA $12.98
- PRQR N/A
- Revenue Growth
- LSEA 28.13
- PRQR 85.91
- 52 Week Low
- LSEA $5.41
- PRQR $1.07
- 52 Week High
- LSEA $14.04
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- LSEA 48.21
- PRQR 50.51
- Support Level
- LSEA $5.79
- PRQR $1.50
- Resistance Level
- LSEA $6.25
- PRQR $2.02
- Average True Range (ATR)
- LSEA 0.31
- PRQR 0.17
- MACD
- LSEA 0.04
- PRQR 0.03
- Stochastic Oscillator
- LSEA 43.02
- PRQR 48.04
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.